Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

A history of HIV survival in the UK

Treatment for HIV has radically improved since the beginning of the epidemic in 1981. HIV-infected people in the UK are now surviving for decades, rather than months or years.

A visual history of HIV survival in the UK

Download a PDF of the full information graphic.


Identifying HIV

People with HIV can only benefit from the advances in the treatment of HIV if they are identified and begin receiving drugs. In 2014, 17% of people living with HIV in the UK remain undiagnosed. The most affected groups of people are men who have sex with men (MSM) and black African men and women.

Estimated number of people in the UK living with HIV

Evolution of HIV care

HIV attacks and depletes the immune system of CD4+ T cells. If infection is left untreated, it can progress to a point were previously harmless microbes become deadly infections, a condition we now know well as AIDS. In the early days of theHIV epidemic, most patients had progressed to AIDS by the time of diagnosis. Medicine could do no more than treat or limit opportunistic infection, and most patients died within a year or two. Today, most patients are diagnosed and begin treatment long before the virus has time to ravage their body’s defence system. And thanks to the development of dozensof new drugs that suppress viral replication, people infected with HIV can live a long life. 

Evolution of HIV care

Market approval key


Acknowldegement: with thanks to Margaret May at University of Bristol and Ghadeer Muqbill, St George’s Hospital, London, for editorial advice and support. 

Citation: The Pharmaceutical Journal URI: 20200169

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • A visual history of HIV survival in the UK
  • Estimated number of people in the UK living with HIV
  • Evolution of HIV care
  • Market approval key

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.